Flow Cytometry – Products

Recent technological advancements have made single-cell multi omics (genomics, proteomics, metabolomics) an increasingly powerful tool for diagnosis, treatment response prediction and treatment selection for cancer. The process begins with disaggregation of a fresh or frozen sample into a single-cell suspension, followed by preparation of a single-cell next-generation sequencing (NGS) library, then data analysis. Find out more...

TransCure bioServices has developed cell line-derived xenograft mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukemia.

Antiverse Ltd has announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors, both displaying versatile binding profiles and nanomolar affinity.

Flow cytometry is an important part of the drug discovery workflow. From screening antibodies to small molecules, combining tests for various analytes in a single panel not only reduces the necessary sample volume but also collects more information in less time, accelerating the drug discovery process.

Bio-Rad Laboratories, Inc. has announced the launch of both the StarBright™ Blue-series and StarBright™ Yellow-series Dyes to provide greater flexibility in conventional and full spectrum flow cytometry applications.

Spatial biology requires highly validated reagents to accurately resolve proteins in the tissue microenvironment. Although immunofluorescence techniques are some of the most commonly used research tools, there are no universally accepted guidelines for antibody validation.

Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. has announced that it has entered into a strategic partnership with Bio-Rad Laboratories, Inc.

The new service is a world first in 3D imaging, allowing the measurement and visualization of tumor growth in animal models across preclinical research, oncology and drug development.

Traditional methods are often low throughput, time-consuming and lack linearity. However, advanced flow cytometry has emerged as a more efficient alternative for biologics development.

With the CellCelector Flex single cell and colony picking platform, you can now effectively assess and verify your clones before deciding which ones to choose. In less than one week, you will obtain monoclonal, viable, and productive colonies from your pool of single cells. Instead of relying on large quantities of plates to produce a winner you can now use actual data to reliably predict the future of your clones. This saves consumable and media costs, incubator space, and most of all valuable time by avoiding missteps, a second cloning round, and unnecessary procedures